Inactive Instrument
Isracann Biosciences Inc. Stock Canadian Securities Exchange
Stocks
IPOT
CA46501D1087
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.06M 5.27M 4.91M 4.5M 8.51M 579M 8.64M 57.83M 22.7M 288M 22.77M 22.27M 966M | P/E 2021 |
-1.24x | P/E 2022 | -2.25x |
|---|---|---|---|---|---|
| Enterprise Value | 5.85M 5.08M 4.73M 4.35M 8.21M 558M 8.33M 55.79M 21.9M 278M 21.97M 21.49M 932M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
99.83% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Ajay Kala
CEO | Chief Executive Officer | - | 20/01/2023 |
Yana Popova
DFI | Director of Finance/CFO | 44 | 15/11/2017 |
Bob Mehr
PRN | Corporate Officer/Principal | - | 15/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Bromley
BRD | Director/Board Member | 36 | 19/12/2019 |
Yana Popova
BRD | Director/Board Member | 44 | 15/11/2017 |
George Vrabec
BRD | Director/Board Member | - | 15/04/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 176 | ||
| +0.21% | +3.65% | -6.09% | -0.23% | 13.96B | ||
| +0.15% | +5.03% | -28.44% | -47.91% | 5.34B | ||
| -1.12% | +7.35% | +5.65% | +10.86% | 5.16B | ||
| +1.56% | +2.99% | +3.30% | -29.48% | 4.18B | ||
| -0.03% | +4.59% | -1.21% | +1.24% | 3.79B | ||
| -0.33% | +0.68% | -0.85% | +7.92% | 3.66B | ||
| +1.51% | +2.28% | -3.24% | +18.97% | 3.57B | ||
| +0.90% | +2.07% | -14.25% | -21.00% | 2.46B | ||
| -2.04% | +4.97% | -1.96% | +54.36% | 1.92B | ||
| Average | +0.08% | +2.19% | -5.23% | -0.59% | 4.89B | |
| Weighted average by Cap. | +0.16% | +2.68% | -5.73% | -3.91% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -25.16M -21.87M -20.35M -18.69M -35.29M -2.4B -35.84M -240M -94.16M -1.2B -94.47M -92.4M -4.01B | -4.69M -4.08M -3.8M -3.49M -6.58M -448M -6.69M -44.76M -17.57M -223M -17.63M -17.24M -748M |
| Net Debt | -1.96M -1.7M -1.58M -1.45M -2.75M -187M -2.79M -18.68M -7.33M -93.07M -7.35M -7.19M -312M | -214K -186K -173K -159K -300K -20.42M -305K -2.04M -801K -10.17M -803K -786K -34.09M |
Employees
-
Sector
Pharmaceuticals
















